Mostra 1 - 20 risultati di 380 ricerca '"Фармакокинетика и Фармакодинамика"', tempo di risposta: 0,27s Raffina i risultati
  1. 1
    О журнале «Фармакокинетика и Фармакодинамика»

    О журнале «Фармакокинетика и Фармакодинамика»

    Pubblicazione 2012-03-01
    “...Фармакокинетика и Фармакодинамика...”
    Testo
    Articolo
  2. 2
    Study of the interaction of the GSB-106 BDNF neurotrophin dipeptide mimetic with the TrkB tyrosine kinase receptor using surface plasmon resonance technology

    Study of the interaction of the GSB-106 BDNF neurotrophin dipeptide mimetic with the TrkB tyrosine kinase receptor using surface plasmon resonance technology di A. V. Tarasiuk, Y. V. Mezentsev, O. V. Gnedenko, P. Yu. Povarnina, A. S. Ivanov

    Pubblicazione 2023-01-01
    “...Фармакокинетика и Фармакодинамика...”
    Testo
    Articolo
  3. 3
    Study of the relationship between the severity of alcoholic cardiomyopathy and the level of alcohol consumption in male and female rats in the model of “home drinking”

    Study of the relationship between the severity of alcoholic cardiomyopathy and the level of alcohol consumption in male and female rats in the model of “home drinking” di S. A. Kryzhanovskii, I. B. Tsorin, E. O. Ionova, V. V. Barchukov, V. N. Stolyaruk, M. B. Vititnova, L. G. Kolik, A. D. Durnev

    Pubblicazione 2023-11-01
    “...Фармакокинетика и Фармакодинамика...”
    Testo
    Articolo
  4. 4
    Изучение фармакодинамики наноразмерной формы феназепама на основе поли (бутил) цианоакрилатных наночастиц

    Изучение фармакодинамики наноразмерной формы феназепама на основе поли (бутил) цианоакрилатных наночастиц...

    Pubblicazione 2012-04-01
    “...Фармакокинетика и Фармакодинамика...”
    Testo
    Articolo
  5. 5
    Regulation of connective tissue development by calcium channel blocking agents in adhesion process

    Regulation of connective tissue development by calcium channel blocking agents in adhesion process di S. V. Skalskii, T. F. Sokolova, S. K. Zyryanov

    Pubblicazione 2017-11-01
    “...Фармакокинетика и Фармакодинамика...”
    Testo
    Articolo
  6. 6
    Экспериментальное исследование биодоступности комбинированного препарата Диоксазид

    Экспериментальное исследование биодоступности комбинированного препарата Диоксазид

    Pubblicazione 2012-03-01
    “...Фармакокинетика и Фармакодинамика...”
    Testo
    Articolo
  7. 7
    Bioequivalence of bisoprolol, coated tablets 10 mg JSC «Chimpharm» Republic of Kazakhstan

    Bioequivalence of bisoprolol, coated tablets 10 mg JSC «Chimpharm» Republic of Kazakhstan di Y. M. Budach, O. E. Kurilo, A. K. Sariev, D. A. Abaimov, M. V. Shiryaev, E. Y. Styrova, S. A. Altynbekov, G. A. Dzholdygulov, V. N. Seryakov, K. S. Altynbekov

    Pubblicazione 2013-04-01
    “...Фармакокинетика и Фармакодинамика...”
    Testo
    Articolo
  8. 8
    Antiarrhythmic properties of N-Deacetyllappaconitine Hydrochloride

    Antiarrhythmic properties of N-Deacetyllappaconitine Hydrochloride di S. A. Kryzhanovskii, M. S. Yunusov, I. B. Tsorin, V. V. Barchukov, E. I. Barchukova

    Pubblicazione 2022-01-01
    “...Фармакокинетика и Фармакодинамика...”
    Testo
    Articolo
  9. 9
    Influence of probiotic lactobacilli on nonspecific resistance and physiological parameters of laboratory animals

    Influence of probiotic lactobacilli on nonspecific resistance and physiological parameters of laboratory animals di A. N. Ovcharova, O. V. Safronova, L. L. Polyakova

    Pubblicazione 2019-02-01
    “...Фармакокинетика и Фармакодинамика...”
    Testo
    Articolo
  10. 10
    Терапевтический лекарственный мониторинг противовирусных препаратов

    Терапевтический лекарственный мониторинг противовирусных препаратов

    Pubblicazione 2020-04-01
    “...Фармакокинетика и Фармакодинамика...”
    Testo
    Articolo
  11. 11
    Evaluation of allergenic properties and immunotoxicity tablet dosage form GML-1 (N-benzyl-N-methyl-1-phenylpyrrolo[1,2-a]pyrazin-3-carboxamide)

    Evaluation of allergenic properties and immunotoxicity tablet dosage form GML-1 (N-benzyl-N-methyl-1-phenylpyrrolo[1,2-a]pyrazin-3-carboxamide) di L. P. Kovalenko, K. V. Korzhova, R. V. Zhurikov, A. D. Durnev

    Pubblicazione 2020-12-01
    “...Фармакокинетика и Фармакодинамика...”
    Testo
    Articolo
  12. 12
    The cardiotropic properties of ZMEI-3 compound – a potential inhibitor of Epac proteins

    The cardiotropic properties of ZMEI-3 compound – a potential inhibitor of Epac proteins di S. A. Kryzhanovskii, G. V. Mokrov, I. B. Tsorin, E. O. Ionova, M. B. Vititnova, V. N. Stolyaruk, I. A. Miroshkina, A. V. Sorokina, A. D. Durnev

    Pubblicazione 2025-01-01
    “...Фармакокинетика и Фармакодинамика...”
    Testo
    Articolo
  13. 13
    About interrelations between levels of a neurotrophic factor of a brain in blood, microelements in hair at young age

    About interrelations between levels of a neurotrophic factor of a brain in blood, microelements in hair at young age di E. G. Pepelyaev, V. A. Semenov, I Yu. Torshin, O. A. Gromova

    Pubblicazione 2020-12-01
    “...Фармакокинетика и Фармакодинамика...”
    Testo
    Articolo
  14. 14
    The antiarrhythmic activity comparative study of Lappaconitine hydrobromide and LMG-124 on the model of aconitine arrhythmia

    The antiarrhythmic activity comparative study of Lappaconitine hydrobromide and LMG-124 on the model of aconitine arrhythmia di V. N. Stolyaruk, I. B. Tsorin, M. B. Vititnova, T. D. Nikiforova, Yu. I. Murinov, M. S. Yunusov, S. A. Kryzhanovskii

    Pubblicazione 2017-03-01
    “...Фармакокинетика и Фармакодинамика...”
    Testo
    Articolo
  15. 15
    Bioequivalence study of fixed-dose combination Losartan + amlodipine + rosuvastatin Sanofi in comparison with coadministered fixed- dose combination Lozap® AM and monocomponent drug Crestor® in healthy subjects

    Bioequivalence study of fixed-dose combination Losartan + amlodipine + rosuvastatin Sanofi in comparison with coadministered fixed- dose combination Lozap® AM and monocomponent dru... di A. L. Khokhlov, D. Yu. Grebenkin, E. K. Faeva, V. I. Kazey, A. A. Khokhlov, A. E. Miroshnikov, O. V. Lebedeva

    Pubblicazione 2022-05-01
    “...Фармакокинетика и Фармакодинамика...”
    Testo
    Articolo
  16. 16
    Study of acute toxicity of the drug Homeovox

    Study of acute toxicity of the drug Homeovox di I. A. Miroshkina, A. V. Sorokina, A. V. Volkova, V. V. Zabrodina, K. S. Kachalov, А. D. Zakharov, S. V. Alekseeva, A. S. Lapitskaya

    Pubblicazione 2020-07-01
    “...Фармакокинетика и Фармакодинамика...”
    Testo
    Articolo
  17. 17
    Effect of GK-1 NGF Loop 4 Dipeptide Mimetic on tumor growth and metastasis of Lewis lung carcinoma in experiment on male C57BL/6 mice

    Effect of GK-1 NGF Loop 4 Dipeptide Mimetic on tumor growth and metastasis of Lewis lung carcinoma in experiment on male C57BL/6 mice di L. P. Kovalenko, R. V. Zhurikov, P. Yu. Povarnina, A. V. Tarasiuk

    Pubblicazione 2023-05-01
    “...Фармакокинетика и Фармакодинамика...”
    Testo
    Articolo
  18. 18
    Открытое, рандомизированное, перекрёстное исследование сравнительной фармакокинетики и биоэквивалентности препаратов Сантодарон и Кордарон

    Открытое, рандомизированное, перекрёстное исследование сравнительной фармакокинетики и биоэквивалентности препаратов Сантодарон и Кордарон...

    Pubblicazione 2012-04-01
    “...Фармакокинетика и Фармакодинамика...”
    Testo
    Articolo
  19. 19
    Clinical pharmacokinetics of а new original dipeptide anxiolytic GB-115

    Clinical pharmacokinetics of а new original dipeptide anxiolytic GB-115 di V. P. Zherdev, G. B. Kolyvanov, A. A. Litvin, V. V. Smirnov, L. G. Kolik, S. Yu. Raskin, N. Yu. Ivashkina, T. A. Gudasheva, S. B. Seredenin

    Pubblicazione 2017-02-01
    “...Фармакокинетика и Фармакодинамика...”
    Testo
    Articolo
  20. 20
    Development and validation of the method for the quantitative determination of methotrexate in a transport medium by HPLC-MS/MS

    Development and validation of the method for the quantitative determination of methotrexate in a transport medium by HPLC-MS/MS di P. Yu. Mylnikov, Yu. Tranova, A. V. Shchulkin, E. N. Yakusheva

    Pubblicazione 2021-09-01
    “...Фармакокинетика и Фармакодинамика...”
    Testo
    Articolo

Strumenti per la ricerca: